CorMedix Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 14.47 million compared to USD 10.57 million a year ago. Basic loss per share from continuing operations was USD 0.25 compared to USD 0.24 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.27 USD | -0.38% | +2.93% | +40.16% |
May. 28 | CorMedix Shares Rise on Multiyear DefenCath Supply Deal | MT |
May. 28 | CorMedix Inc. Announces Commercial Agreement with Top Tier Dialysis Provider | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.16% | 290M | |
+16.03% | 78.51B | |
+13.10% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024